Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Caring & giving/
  4. Ensuring babies have the first breath of life
Our-Giving-Ensuring-Babies-Have-the-First-Breath-of-Life
When Sun Yan’s daughter Wu Yuxuan was born, she could not breathe on her own until nurses performed life-giving resuscitation.

Ensuring babies have the first breath of life

When Sun Yan’s daughter Wu Yuxuan was born, she could not breathe on her own until nurses performed life-giving resuscitation.

The Helping Babies Breathe (HBB) initiative trains health care workers in low-resource settings to intervene when newborns have birth asphyxia, the inability to breathe at birth. HBB is committed to increase the availability of skilled birth attendants at every birth. Nurses and midwives with HBB training have the skills to resuscitate over 90% of babies with birth asphyxia.

In 2011, Johnson & Johnson made a $2 million 5-year investment to implement HBB in Malawi and Uganda in partnership with Save the Children. The partnership has trained more than 1000 skilled birth attendants, mostly midwives.

HBB is an extension of over a decade of work with the Neonatal Resuscitation Program to address birth asphyxia, including a joint effort in China by Johnson & Johnson, the Chinese Ministry of Health and the American Academy of Pediatrics that has saved more than 190,000 babies. Since the program launched in 2004, newborn death caused by birth asphyxia has declined in China by more than 50% percent.

To date, our programs address birth asphyxia in more than 12 countries including China, India, Indonesia, Vietnam, Nepal, Pakistan, Uganda, Malawi, Kenya, Ethiopia, Ghana and South Africa.

More from Johnson & Johnson

How Johnson & Johnson is advancing the fight against Alzheimer’s disease

After decades of commitment to understanding this neurodegenerative disease, company scientists have developed innovative therapies and tools that can potentially slow its progression and ease the psychological toll on patients and caretakers. A cure is still elusive—but preventing the disease may be within reach.

Is this the end of one-size-fits-all treatments for depression?

Learn how Johnson & Johnson is working to better address the needs of the 7 in 10 people with depression whose treatments aren’t providing enough relief.

What is inflammation?

Inflammation is the body’s natural response to injury or infection. But when it lingers, inflammation can lead to inflammatory bowel disease, psoriasis and rheumatoid arthritis, among other immune-mediated inflammatory diseases. Learn how Johnson & Johnson is innovating to help bring relief to those living with chronic inflammatory conditions.